Opportunistic Infections Citation List:
January 7 - January 20, 2011
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Isolation and characterization of antifungal peptides produced by Bacillus amyloliquefaciens LBM5006. Benitez, L.B., R.V. Velho, M.P. Lisboa, L.F. da Costa Medina, and A. Brandelli. Journal of Microbiology, 2010. 48(6): p. 791-7; PMID[21221936].
[Pubmed]. OI_0106-011911.
2. Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002 - 2010). Calugi, C., A. Trabocchi, and A. Guarna. Expert Opinion on Therapeutic Patents, 2011. [Epub ahead of print]; PMID[21241212].
[Pubmed]. OI_0106-011911.
3. Purification, characterization and inhibition of sterol C24-methyltransferase from Candida albicans. Ganapathy, K., R. Kanagasabai, T.T. Nguyen, and W.D. Nes. Archives of Biochemistry and Biophysics, 2011. 505(2): p. 194-201; PMID[20946868].
[Pubmed]. OI_0106-011911.
4. Antimicrobial activity of Citrox((R)) bioflavonoid preparations against oral microorganisms. Hooper, S.J., M.A. Lewis, M.J. Wilson, and D.W. Williams. British Dental Journal, 2011. 210(1): p. 1-5; PMID[21217705].
[Pubmed]. OI_0106-011911.
5. In-vitro antifungal and antibacterial activities of pentacycloundecane tetra-amines. Onajole, O.K., Y. Coovadia, T. Govender, H.G. Kruger, G.E. Maguire, D. Naidu, N. Singh, and P. Govender. Chemical Biology & Drug Design, 2011. [Epub ahead of print]; PMID[21241455].
[Pubmed]. OI_0106-011911.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
6. The effect of 5-substitution on the electrochemical behavior and antitubercular activity of PA-824. Bollo, S., L.J. Nunez-Vergara, S. Kang, L. Zhang, H.I. Boshoff, C.E. Barry, 3rd, J.A. Squella, and C.S. Dowd. Bioorganic and Medicinal Chemistry Letters, 2011. 21(2): p. 812-7; PMID[21168331].
[Pubmed]. OI_0106-011911.
7. Cisplatin inhibits protein splicing, suggesting inteins as therapeutic targets in mycobacteria. Zhang, L., Y. Zheng, B. Callahan, M. Belfort, and Y. Liu. The Journal of Biological Chemistry, 2011. 286(2): p. 1277-82; PMID[21059649].
[Pubmed]. OI_0106-011911.
Citations from the ISI Web of Knowledge Listings for O.I.
8. 2- 4-(4-Methoxyphenylcarbonyloxy)benzylidene -6-dimethylaminomethyl cyclohexanone hydrochloride: A Mannich base which inhibits the growth of some drug-resistant strains of Mycobacterium tuberculosis. Das, S., U. Das, B. Bandy, D.K.J. Gorecki, and J.R. Dimmock. Pharmazie, 2010. 65(11): p. 849-850; ISI[000285076700013].
[WOS]. OI_0106-011911.
9. Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis. Ferreira, M.D., A.L.P. Candea, M. Henriques, M.C.S. Lourenco, C.R. Kaiser, and M.V.N. de Souza. Letters in Drug Design & Discovery, 2010. 7(10): p. 754-758; ISI[000285238300008].
[WOS]. OI_0106-011911.
10. Secondary Metabolites from the Sponges Aplysina fistularis and Dysidea sp and the Antituberculosis Activity of 11-Ketofistularin-3. Gandolfi, R.C., M.B. Medina, R.G.S. Berlinck, S.P. Lira, F.C.D. Galetti, C.L. Silva, K. Veloso, A.G. Ferreira, E. Hajdu, and S. Peixinho. Quimica Nova, 2010. 33(9): p. 1853-1858; ISI[000285021300006].
[WOS]. OI_0106-011911.
11. Synthesis and Antifungal Activities in vitro of Novel Pyrazino 2,1-a Isoquinolin Derivatives. Tang, H., C.H. Zheng, J.G. Lu, B.Y. Fu, Y.J. Zhou, and J. Zhu. Acta Chimica Sinica, 2010. 68(22): p. 2338-2346; ISI[000285176900014].
[WOS]. OI_0106-011911.